Erik Wegner

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Max Planck Institute of Colloids and Interfaces(Current)

Freie Universität Berlin

Johannes Gutenberg University Mainz

University Medical Center of the Johannes Gutenberg University Mainz

Friedrich-Alexander-Universität Erlangen-Nürnberg

Erik Wegner is an author at Max Planck Institute of Colloids and Interfaces specializing in immunology, vaccine-preventable diseases, and glycoconjugate vaccine design.

ORCID

Publications per year

2016–2023

Publications

Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections

Felix Broecker, Christopher E. Martin, Erik Wegner et al. · Cell chemical biology · 2016 · 40 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Synthetic Oligosaccharide-Based Vaccines Protect Mice from <i>Clostridioides difficile</i> Infections

Felix Broecker, Erik Wegner, Bruna M. S. Seco et al. · ACS Chemical Biology · 2019 · 24 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The effect of losartan on the development of post-traumatic joint stiffness in a rat model

Erik Wegner, Tim Mickan, Sebastian Truffel et al. · Biomedicine & Pharmacotherapy · 2023 · 13 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Pleiotropic Long-Term Effects of Atorvastatin on Posttraumatic Joint Contracture in a Rat Model

Erik Wegner, Ekaterina Slotina, Tim Mickan et al. · Pharmaceutics · 2022 · 11 citations · Full text

Veterinary Medicine, Orthopaedic Surgery, Surgery +16

1–4 of 4